The Changing Face of Beauty, a global study conducted by Allergan, reflects a shift in consumer expectations; women today opt for products and procedures to improve how they feel, rather than simply how they look.
A bimatoprost-containing eyelash product can enhance lash growth when used for six months but the treatment is not without side effects, according to recent research.
Pharmaceutical giant Allergan plans to release an eyelash growth
stimulator having recently fought a number of alleged patent
infringement cases over the drug.
The FDA has agreed to evaluate an anti-wrinkle injection treatment
from France-based pharmaceutical company Ipsen which if approved
would provide a rival for Allergan's Botox.
The cosmetics industry needs to abandon products promising
perfection and focus on enhancement as a cross cultural study
reveals that the vast majority of women want to look natural.
